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We recently reported a dramatic increase in the prevalence of carbapenem-resistant Acinetobacter baumannii infections in
the intensive care unit (ICU) of a Vietnamese hospital. This upsurge was associated with a specific oxa23-positive clone that
was identified by multilocus VNTR analysis. Here, we used whole-genome sequence analysis to dissect the emergence of
carbapenem-resistant A. baumannii causing ventilator-associated pneumonia (VAP) in the ICU during 2009–2012.
To provide historical context and distinguish microevolution from strain introduction, we compared these genomes with those
of A. baumannii asymptomatic carriage and VAP isolates from this same ICU collected during 2003–2007. We identified
diverse lineages co-circulating over many years. Carbapenem resistance was associated with the presence of oxa23, oxa40,
oxa58 and ndm1 genes in multiple lineages. The majority of resistant isolates were oxa23-positive global clone GC2; fine-
scale phylogenomic analysis revealed five distinct GC2 sublineages within the ICU that had evolved locally via independent
chromosomal insertions of oxa23 transposons. The increase in infections caused by carbapenem-resistant A. baumannii was
associated with transposon-mediated transmission of a carbapenemase gene, rather than clonal expansion or spread of a
carbapenemase-harbouring plasmid. Additionally, we found evidence of homologous recombination creating diversity within
the local GC2 population, including several events resulting in replacement of the capsule locus. We identified likely donors of
the imported capsule locus sequences amongst the A. baumannii isolated on the same ward, suggesting that diversification
was largely facilitated via reassortment and sharing of genetic material within the localized A. baumannii population.
Keywords: capsule switching; hospital acquired infection; imipenem resistance; local evolution; molecular epidemiology;
phylogenomic analysis.
Abbreviations: AIC, Akaike information criterion; CC, clonal complex; ESS, effective sample size; GC, global clone; HPD,
highest posterior density; HTD, Hospital for Tropical Diseases; ICU, intensive care unit; KL, capsule biosynthesis locus;
MCMC, Markov Chain Monte Carlo; ML, maximum-likelihood; MLVA, multilocus VNTR analysis; MRCA, most recent
common ancestor; VAP, ventilator associated-pneumonia.
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Data Summary
1. Supplementary data (Table S1, Figs S1–S6, File S1,
File S2 and Note S1) have been deposited in FigShare:
10.6084/m9.figshare.2064357
2. Illumina paired-end short-read sequences reported in
this paper have been deposited in the European Nucleo-
tide Archive under project ERP001080. Individual
isolate accession numbers are provided in Table S1.
3. Novel annotated sequences have been submitted to
GenBank as plasmid p255n_1 (accession number
KT852971), plasmid pBAL_204 (accession number
KT946773), transposon Tn2008VAR (accession
number KT852972), capsule loci KL32 (accession
number KT359615), KL49 (accession number
KT359616) and KL58 (accession number KT359617).
The novel insertion sequence was submitted to ISfinder
as ISAba33. Schematic representations of novel anno-
tated sequences have been deposited in FigShare: 10.
6084/m9.figshare.2064357
4. Tree files (Bayesian and maximum-likelihood), meta-
data (CSV) and Gubbins recombinant blocks (GFF3)
files for display in Phandango (previously known as
JScandy; http://jameshadfield.github.io/phandango/)
are deposited in FigShare: 10.6084/m9.figshare.2064357
Introduction
Over the past three decades, Acinetobacter baumannii has
become increasingly implicated in outbreaks of multiply
antibiotic-resistant hospital-acquired infections worldwide
(Antunes et al., 2014; Bouvet & Grimont, 1987; Perez et al.,
2007, 2011). The organism is now universally recognized as
one of the six most problematic hospital-adapted antimi-
crobial-resistant bacterial pathogens, contributing the ‘A’
in the ‘ESKAPE’ pathogens (Rice, 2008). The majority
of hospital-acquired A. baumannii infections are caused
by two globally disseminated clones, known as global
clones GC1 and GC2. In intensive care units (ICUs),
ventilator-associated pneumonia (VAP) is the second
most common hospital-acquired infection (Kalanuria
et al., 2014), affecting up to a quarter of mechanically
ventilated patients (Chastre & Fagon, 2002), and
has an attributable mortality risk of *13 % (Melsen
et al., 2013). VAP caused by antimicrobial-resistant
A. baumannii is becoming increasingly common in indus-
trialized countries. Antimicrobial-resistant A. baumannii
have been isolated in up to 45 % of VAP cases in the
ICU at the Hospital for Tropical Diseases (HTD), Ho
Chi Minh City, Vietnam (Nhu et al., 2014).
A. baumannii are intrinsically resistant to chloramphenicol
and florfenicol, and resistance to all other first-line anti-
microbials (sulphonamides, tetracycline and ampicillin)
has become largely ubiquitous amongst hospital-acquired
A. baumannii since the 1980s (Bergogne-Be´re´zin &
Towner, 1996). Resistance to cephalosporins and fluoro-
quinolones emerged in the 1990s, leaving carbapenems
(particularly imipenem) as the mainstay for empirical
treatment (Bergogne-Be´re´zin & Towner, 1996). Imipenem
first became available for the treatment of microbial infec-
tions in 1985 (Papp-Wallace et al., 2011). Coincidentally,
imipenem-resistant A. baumannii were first isolated in
1985 from a hospital in which imipenem had never been
used (Paton et al., 1993), with resistance later found to
be conferred by the oxa23 gene (Donald et al., 2000).
Thus, the mechanisms of resistance to imipenem already
existed in the A. baumannii population well before the
first use of imipenem (Paton et al., 1993; Poirel et al.,
2008). Over the last decade, imipenem-resistant
A. baumannii infections have been observed more widely,
prompting the use of colistin for antimicrobial therapy
(Garonzik et al., 2011). Although colistin is effective
against most carbapenem-resistant A. baumannii, it is a
last-resort treatment due to toxicity (e.g. Evans et al.,
2013; Ordooei Javan et al., 2015; Spapen et al., 2011) and
resistance to colistin in A. baumannii is also emerging
(Cai et al., 2012; Qureshi et al., 2015). Being naturally com-
petent (Wilharm et al., 2013) and able to form biofilms
(Madsen et al., 2012; McQueary et al., 2012; Tomaras
et al., 2003), homologous recombination is common in
Impact Statement
Infections caused by antibiotic-resistant bacteria pose
a heavy burden on human health globally. Where
antibiotics are in sustained usage, bacteria have
been shown to rapidly evolve to become drug resist-
ant. The problem of antibiotic-resistant bacterial
infections in intensive care units (ICUs) is becoming
increasingly common and understanding the means
by which bacteria develop antibiotic resistance in
the ICU may help to prevent or slow this process in
the future, extending the life of new antibiotics.
Acinetobacter baumannii is one of the most proble-
matic bacterial species that cause antibiotic-resistant
infections in ICU patients. In this study, we used
genome sequencing to retrace the evolution of resist-
ance to an important class of antibiotics (carbape-
nems) amongst A. baumannii bacteria circulating in
an ICU ward in Vietnam. We found that after carba-
penems were introduced as a common treatment for
infections in the ICU in 2008, several different strains
of A. baumannii that were susceptible to carbape-
nems in earlier years became resistant by acquiring
new genes, which encoded carbapenemase enzymes
that break down carbapenem-based drugs. These
newly resistant strains became very common on the
ward in later years, so that most infections could
no longer be effectively treated using carbapenems.
In finding strong evidence for the repeated local
emergence of drug resistance in response to local
usage of the drug, our findings provide a predictive
framework for healthcare practitioners dealing with
these types of infection.
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A. baumannii populations; however, few genomic studies
have investigated this in detail.
We recently investigated the aetiology of VAP in the ICU at
the HTD (Nhu et al., 2014). Acinetobacter was the domi-
nant genus implicated in VAP and we documented an
increase in its isolation from 28 % of VAP during 2000–
2007 to 46 % in 2010 (Nhu et al., 2014). Approximately
15 % of VAP-associated Acinetobacter were resistant to
imipenem during 2002–2007. Imipenem was approved
for empirical treatment of VAP in this ICU in 2008, follow-
ing which the frequency of imipenem resistance increased
to 46 % of A. baumannii VAP isolates in 2009 and 86 %
in 2010 (Nhu et al., 2014). Multilocus VNTR analysis
(MLVA) and PCR profiling of carbapenemase genes
indicated that this increase was largely attributable to
A. baumannii sharing the same MLVA profile (MLVA6)
and carrying the oxa23 gene (Nhu et al., 2014). Thus,
we hypothesized that the dominant VAP-associated
A. baumannii subtype constituted a single clone that had
been introduced and then maintained on the ICU ward,
likely due to sustained imipenem usage. However, MLVA
data could not resolve ancestor–descendent relationships
among the samples nor identify whether GC1 or GC2
were present.
Here, we used whole-genome sequencing to study the
population of imipenem-resistant A. baumannii isolated
from VAP on the HTD ICU during 2008–2012 and to
investigate their relationship to imipenem-susceptible
A. baumannii isolated from VAP or asymptomatic carriage
on the same ICU ward in 2003–2007.
Methods
Bacterial isolates and DNA sequencing. To examine
the relationships between A. baumannii carbapenem-
resistant and -susceptible isolates, we sequenced the
genomes of isolates collected during two different studies
(from two different time periods) in the same ICU ward
at the HTD. This ICU is largely devoted to the treatment
of tetanus patients (Nhu et al., 2014). The first study
aimed to characterize asymptomatic colonization (carri-
age) of patients by potentially pathogenic commensal
bacteria (including Acinetobacter spp., Klebsiella pneu-
moniae, Pseudomonas aeruginosa and Staphylococcus
aureus) during 2003–2007 (Schultsz et al., 2013). The
following swabs were collected from patients entering the
ward within 48 h of admission: nasal swab (‘n’ or ‘N’),
axilla swab (‘ax’), anal swab (‘an’) and skin swabs at the
cannula tip point of entry (‘c’). These swabs yielded 70
A. baumannii asymptomatic carriage isolates available for
sequencing. A total of 12 A. baumannii VAP isolates
from this period were identified in a review of laboratory
inventory, so these were also sequenced for comparison.
The second study (described in Nhu et al., 2014) aimed
to understand the bacterial aetiology of emerging drug-
resistant VAP on the ward and reviewed bacterial isolates
cultured from specimens from intubated patients via
bronchoalveolar lavage (BAL) or tracheal washes (UV).
From this latter study, a total of 77 A. baumannii
isolated during 2008–2012 were available for sequencing.
These isolates were all considered to be causative agents
of VAP; no asymptomatic carriage isolates were collected
during this time period. The list of all 159 A. baumannii
isolates that were retrospectively combined for the
present study is provided in Table S1.
Genomic DNA was extracted using a Wizard Genomic
Extraction kit (Promega) and subjected to 96-plex bar-
coded 100 bp paired-end sequencing via Illumina HiSeq
2500, as described previously (Holt et al., 2012). Twelve
of the infection isolates failed sequencing, leaving a total
of 147 genomes for analysis. Sequence reads are available
in the European Nucleotide Archive under project
ERP001080. Individual accession numbers are provided
in Table S1.
Antimicrobial susceptibility testing. Antimicrobial
susceptibilities were determined at the time of isolation
by the modified Kirby–Bauer disk diffusion method, as
recommended by the Clinical and Laboratory Standards
Institute (CLSI, 2011): piperacillin/tazobactam (100/10 mg),
imipenem (10 mg), amikacin (30 mg), ceftazidime (30 mg),
ceftriaxone (30 mg), ciprofloxacin (5 mg), gentamicin
(30 mg) and colistin (10 mg). Mueller–Hinton agar and
antimicrobial discs were purchased from Unipath. For
colistin, imipenem, ceftazidime and ceftriaxone, MICs
were determined by E-test based on the manufacturer’s
recommendations (AB Biodisk). The results were
interpreted as resistant or sensitive according to current
Clinical and Laboratory Standards Institute guidelines.
Escherichia coli ATCC 25922 was used as the control for
these assays.
SNP identification and phylogenomic analysis.
Whole-genome sequences were inferred by mapping
Illumina reads against the 3 940 614 bp reference genome
of A. baumannii GC2 strain 1656-2 (GenBank accession
number CP001921.1) using the RedDog mapping
pipeline (https://github.com/katholt/RedDog). Briefly,
RedDog uses Bowtie version 2.2.3 (Langmead & Salzberg,
2012) to map reads to the reference sequence, then high-
quality SNPs with Phred quality score i30 are extracted
from the resulting alignments using SAMtools version
0.1.19. SNPs were filtered to exclude those with five or
more reads mapped or with w2.5 times the mean read
depth (representing putative repeated sequences), or with
heterozygous (ambiguous) allele calls. For each SNP that
passed these criteria in any one isolate, consensus allele
calls for the SNP locus were extracted from all genomes
(ambiguous base calls and bases with Phred quality v20
were treated as unknown alleles and represented with a
gap character). SNPs with confident homozygous allele
calls (Phred quality i20 calculated by SAMtools con-
sensus) in w90 % of the A. baumannii genomes (repre-
senting a ‘soft’ core genome of common A. baumannii
Repeated emergence of carbapenem-resistant A. baumannii
http://mgen.microbiologyresearch.org 3
sequences) were concatenated to produce an alignment of
217 290 variant sites.
Maximum-likelihood (ML) analysis was performed using
the GTR model with a gamma distribution of rate hetero-
geneity (GTR+G) using RAxML version 8.1.16
(Stamatakis, 2014). We modelled rate heterogeneity due
to the high level of recombination known to occur in
A. baumannii (Madsen et al., 2012). We did not apply an
ascertainment bias correction because the variable sites
under analysis were those obtained from whole-genome
sequencing and not simply from typing of known variable
sites. ML analyses were performed 10 times with 100 boot-
strap replicates per run. Likelihood scores were compared
between runs to confirm that all runs had converged on
a similar likelihood; we selected the single tree with the
highest likelihood as the best tree.
From the SNP alignment of 147 isolates, we extracted a
SNP alignment for the 66 GC2 isolates including only
the 13 950 SNPs that varied amongst these GC2 genomes.
RAxML analyses were repeated 10 times with 100 boot-
strap replicates per run. For these analyses we used empiri-
cal base frequencies and a GTR best-fit model of nucleotide
substitution. The substitution model was estimated under
the Akaike information criterion (AIC; Akaike, 1974) using
MrModeltest version 2.3 (https://github.com/nylander/
MrModeltest2) in PAUP* (http://paup.csit.fsu.edu/). Tem-
poral signal (‘clock-likeness’) captured in the ML trees was
assessed using Path-O-Gen version 1.4 (Drummond et al.,
2012), which performs linear regression of root-to-tip ML
branch distances (y) on year of isolation (x). Tree topologies
were rooted prior to temporal analysis using an outgroup
from clonal complex CC10.
Visualization of recombination. In order to visualize
clusters of SNPs that were likely imported into the
A. baumannii genomes via recombination events, we
generated plots of SNP density distributions along the
GC2 strain 1656-2 reference genome using R (version
3.2.1). Taking the first isolate in the alignment as a
baseline sequence, we calculated the number of SNPs
between the baseline sequence and each other isolate, in
1 kbp windows. The resulting values, which represent
density of SNPs per 1 kbp along the reference genome,
were plotted as a heatmap, ordered against the ML tree
and output to a PNG image file. This process was
applied iteratively, taking each isolate in turn as the
baseline genome. The resulting sequence of PNG files
was combined into an image-sequence movie file (File S1).
Additionally, we inferred split networks to assess tree-like-
ness of the phylogenetic structure in the SNP alignments
using SplitsTree4 (Huson & Bryant, 2006) with default set-
tings (uncorrected-p distance, cyclic splits computed using
NeighbourNet and ordinary least-squares variance).
Recovering a recombination-free phylogenetic tree
for GC2. We made a number of attempts to detect
recombinant sites within the GC2 population. These
analyses were performed on a pseudo-whole-genome
alignment for GC2 in which each isolate genome was
reconstructed by copying the reference sequence and
replacing the SNP sites with alleles from the isolate in
question. Note that after the recombination detection
analysis, invariant sites were removed and the alignment
was reduced to those common genomic sites that were
present in i90 % of the isolates under study.
Recombinant sites were identified and removed using:
(i) ClonalFrameML (Didelot & Wilson, 2015) with default
settings and 100 bootstrap replicates, and (ii) v1.1.2 (Crou-
cher et al., 2015) for 20 iterations with default settings. The
resultant recombination-free alignments of variant sites
were inspected using SplitsTree4 to build split networks.
In addition, as we expected a strong temporal signal
within the GC2 clone similar to that observed within
other Gram-negative clones, such as Shigella sonnei (Holt
et al., 2012), Vibrio cholerae (Mutreja et al., 2011) or Sal-
monella enterica Typhimurium (Okoro et al., 2012), we
assessed the strength of temporal signal before and after
the various recombination detection procedures by infer-
ring ML trees from the variable sites in the alignments
using RAxML and then analysing these in Path-O-Gen ver-
sion 1.4 (Drummond et al., 2012). As the tree obtained
after Gubbins analysis recovered the strongest temporal
signal, we utilized the Gubbins-filtered alignment for
further analysis.
We performed time-calibrated Bayesian phylogenetic
inference on the post-Gubbins SNP alignment (457 sites)
using BEAST version 1.8.0 with the AIC-selected GTR+G
best-fit substitution model, empirical base frequencies, a
strict molecular clock and a coalescent (constant size)
tree prior. BEAST Markov Chain Monte Carlo (MCMC)
analyses were repeated eight times starting each run from
a random seed and a random tree. MCMC analyses were
continued for 10|106 iterations, sampling every 1000
iterations. After removing a burn-in of 100 samples (i.e.
1|106 MCMC iterations) from each file, logs were com-
bined using LogCombiner version 1.8 to give 72 000
post-burn-in samples (i.e. 72|106 MCMC iterations).
Effective sample sizes (ESSs) for all parameters of interest
were ww1000 as determined by analysis with Tracer ver-
sion 1.6. Burn-in was 10 % of the chain length. Post-
burn-in trees were combined using LogCombiner and
summarized using TreeAnnotator version 1.8. The
common ancestor summary tree was then recovered
from the set of trees (n572 000 trees) in the posterior
sample so that every clade in the summary tree was
assigned an age using the mean of the clade age in all pos-
terior trees (Heled & Bouckaert, 2013).
MLST analysis and detection of acquired resistance
genes from sequence reads. SRST2 (Inouye et al.,
2014) was used with default settings to identify MLSTs
and acquired resistance genes directly from reads. For
MLST analysis, we used both the Institut Pasteur and
M. B. Schultz and others
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University of Oxford MLST databases (http://pubmlst.org/
abaumannii/; downloaded 3 June 2015). All sequence types
reported in the text are based on the Pasteur scheme;
however, those inferred using the Oxford scheme are also
provided for comparison in Table S1. For acquired
resistance genes we used the SRST2-formatted version of
the ARG-ANNOT database (Gupta et al., 2014), distributed
with SRST2 (Inouye et al., 2014).
Genome assembly. Each 100 bp paired-end read set was
assembled de novo using SPAdes version 3.6.1 (Bankevich
et al., 2012), with k-mer sizes 21, 33, 55, 77 and 91, error
correction with BayesHammer (Langmead & Salzberg,
2012), and mismatch correction.
Genetic context and copy number of carbapenemase
genes. The genetic contexts of carbapenemase genes
(oxa23, oxa40, oxa58 and ndm1) were explored in detail
via manual inspection of the SPAdes assembly graphs
using Bandage version 0.7.0 (Wick et al., 2015). All isolates
carrying the oxa23 gene were confirmed to carry the gene
either within Tn2006 (Corvec et al., 2007) or a variant of
Tn2008 (Adams-Haduch et al., 2008). These transposons
are mobilized by ISAba1 (GenBank accession number
AY758396) and it was not possible to determine, using the
Illumina short reads, which of the multiple insertions of
ISAba1 in each genome were associated with the
transposon and which represented other ISAba1
insertions. However, we were able to investigate the
ISAba1 insertion sites in detail using ISMapper (Hawkey
et al., 2015) to identify all insertion sites for ISAba1
relative to the reference chromosome sequence (GC2
strain 1656-2; GenBank accession number CP001921.1)
and using Bandage to investigate whether ISAba1 was
present within additional locations, including the Aci6
plasmid (pA85-3 from a GC1 strain; GenBank accession
number KJ493819.1). As oxa23 was only found in the
chromosome, copy number of oxa23 was inferred from the
distribution of ratios of oxa23 mapping depths to
respective mean chromosome mapping depths. In the
cases of isolates carrying oxa58, inspection of the assembly
graphs in Bandage confirmed that all oxa58 genes were
flanked by ISAba3. In most cases there was a single
insertion site for ISAba3. The surrounding sequence was
extracted and annotated using the automated annotation
pipeline Prokka version 1.10 (Seemann, 2014), followed
by manual annotation of acquired resistance genes (by
comparison with the ARG-ANNOT database; Gupta et al.,
2014) and insertion sequences (by comparison with the
ISfinder database; Siguier et al., 2006). The genetic
contexts of oxa40 and ndm1 were investigated using the
same approach.
Analysis of the capsule locus in GC2. We used BLASTN
version 2.2.31+ (Altschul et al., 1990) to search the
assemblies of GC2 genomes for the capsule biosynthesis
locus (KL) flanking genes mviN (GenBank accession
number CP001182, locus tag AB57_0088) and IldP
(GenBank accession number CP001182, locus tag
AB57_0116). For the 12 genomes in which the KL was
split across multiple contigs, we used Bandage version
0.7.0 (Wick et al., 2015) to inspect the assembly graph
and to extract the sequence for the contiguous path
through the KL. For each of the KL types identified in
more than one GC2 isolate (KL2, KL49 and KL58),
intra-KL sequence alignments were inferred using MAFFT
version 7.245 (Katoh & Standley, 2013). Intra-locus
diversity was then assessed by counting the variable sites
in each of the alignments. Synteny alignments and
sequence comparisons between KL2 and KL58 sequences,
which share extensive sequence similarity, were made
using BLASTN and Mauve version 2.3.1 (Darling et al.,
2004), and visualized using genoPlotR version 1.1 (Guy
et al., 2010) and ACT (Carver et al., 2005). Assessment of
sharing and reassortment of KLs within GC2, or between
GC2 and CC10, via horizontal transfer was made after
mapping reads to the KL2 reference sequence using
RedDog, extracting SNPs as described above for
phylogenetic analysis and visualizing recombination as
described above (File S2). KLs were annotated as
described in Kenyon & Hall (2013).
Ancestral state reconstruction of GC2 capsule types.
To infer ancestral KL types of lineages in the GC2 tree, we
performed multistate ancestral state reconstruction using
BayesTraits version 2.0 (Pagel et al., 2004). We used the
multistate implementation in BayesTraits to reconstruct
the evolution of discrete KL types (four states: KL2,
KL32, KL49 or KL58) on the set of phylogenetic trees
(i.e. 72 000 pooled post-burn-in trees from the BEAST
analysis). We used the MCMC implementation with a
reversible jump and an exponential prior with a mean of
10. The analysis was repeated eight times, continuing
each run for 10|106 iterations and sampling from the
posterior every 1000 iterations. Run log-files were
examined using R.
Results and Discussion
Population structure of A. baumannii in the ICU
The genomes of 147 A. baumannii isolates from VAP
(n577) and asymptomatic carriage (n570) were available
for analysis. MLST analysis of the genome sequences, using
the seven-locus Institut Pasteur scheme, identified 21
sequence types (Table S1). Genome-wide SNP analysis
identified 217 290 core genome SNPs, which were sub-
jected to ML phylogenetic analysis. The core genome
phylogeny and MLST structure identified similar popu-
lation structures, and were used to classify the isolates
into six strongly supported clonal groups plus an
additional group of diverse strains (n516) (Fig. 1a). The
six strongly supported clonal groups were: GC2 (ST2 and
its single locus variants: ST570 and ST571), GC1 (ST1),
CC10 (ST10 and its single-locus variants: ST23 and
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ST575), CC16 (ST16 and its single-locus variant: ST452),
ST25 and ST686. The isolates previously typed as
MLVA6 and MLVA8 (Nhu et al., 2014) belonged to GC2
and CC10, respectively.
The temporal distribution of various genotypes is shown in
Fig. 1(b). Of the sequenced isolates from 2003 to 2007
(n581), 86 % were from asymptomatic carriage. These
early carriage isolates were genetically diverse, and
included i10 isolates each from ST686 (32 %), GC2
(24 %), CC10 (20 %) and ST25 (12 %). The VAP isolates
from this period (n511) fell within these same clonal
groups, with the exception of a single VAP isolate of
ST375, which was not represented within the asympto-
matic carriage isolates. These data are consistent with the
notion that carriage and VAP-associated isolates derive
from the same population of A. baumannii on the ward,
with opportunistic VAP infections arising following con-
tact with a contaminated source (e.g. ventilator tubing).
The later VAP isolates (n566), collected from 2009 to
2012, exhibited less genetic diversity and were dominated
by GC2 (71 %), with smaller numbers of CC10 (9 %),
CC16 (6 %) and occasional less commonly isolated strains
(ST52, ST108, ST109, ST142 and three novel sequence
types: ST754, ST755 and ST756).
Most isolates (75 %) were resistant to amikacin, gentami-
cin, piperacillin/tazobactam, ciprofloxacin, ceftazidime
and ceftriaxone, including isolates from all of the
common clonal groups (GC1, GC2, CC10, CC16, ST109,
ST25, ST52 and ST686; see Table S1). Fewer than 6 % of
isolates were susceptible to two or more of these antibiotics
(Table S1). Our previous review of imipenem-resistant
VAP showed 15 % of VAP-associated Acinetobacter were
resistant to imipenem during 2002–2007, rising to 86 %
in 2010 (Nhu et al., 2014). Eleven A. baumannii VAP iso-
lates from 2002 to 2007 were available for sequencing in
the present study and all of these were susceptible to imi-
penem (Fig. 2). Of the 70 carriage isolates from this period,
all were imipenem-sensitive except for two GC1 isolates
from 2007, which, notably, were the only GC1 isolates in
this collection (MICs are shown in Fig. 2). Of the 66
post-2008 VAP isolates that were successfully sequenced,
only nine (14 %) were susceptible to imipenem. The imi-
penem-resistant VAP isolates belonged to a variety of
clones: GC2 (n547), CC10 (n55), CC16 (n51), and
single isolates from ST52, ST108 and two novel singleton
sequence types (ST755 and ST756) (Fig. 2). As GC2,
CC10 and CC16 were also detected amongst the earlier
isolates from the same ward, these data suggest that
imipenem-resistant A. baumannii emerged on the ward
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Fig. 1. Phylogenetic and temporal structure of the ICU A. baumannii isolates. (a) Unrooted ML core genome phylogeny for all
sequenced isolates. Clonal lineages are coloured and labelled according to their sequence type (defined using the Pasteur MLST
scheme). (b) Temporal distribution of sequenced isolates according to presence of acquired oxa23 or other carbapenemase genes;
coloured by clone, as in (a). ‘Other’ includes carbapenemase genes oxa40, oxa58 and ndm1.
M. B. Schultz and others
6 Microbial Genomics
on multiple occasions, within clones that had been pre-
viously circulating on the ICU.
Genetic determinants of imipenem resistance
We identified at least one carbapenemase gene (oxa23,
oxa40, oxa58 or ndm1) in each imipenem-resistant isolate
(Table S1). These were present in a variety of different gen-
etic contexts and in variable copy numbers (Figs S1 and S2,
summarized in Table 1). The oxa40, oxa58 and ndm1 genes
were rare and mostly plasmid associated (Table 1,
Note S1). We were able to completely assemble two
novel circular plasmids carrying carbapenemase genes
(Fig. S3; p255n_1 containing oxa58, deposited under Gen-
Bank accession number KT852971, and pBAL_204 con-
taining oxa40, deposited under GenBank accession
number KT946773).
The most common carbapenemase gene was oxa23, which
was present in 93 % of imipenem-resistant isolates, includ-
ing 47 GC2 isolates, five CC10 isolates and the two GC1
carriage isolates from 2007 (Fig. 1b). The oxa23 gene was
generally encoded within a Tn2006 transposon, present
in one to three copies. Four GC2 isolates carried an
oxa23 variant (with a SNP leading to an amino acid substi-
tution L125V) located within a Tn2008-like transposon
(submitted as Tn2008VAR under GenBank accession
number KT852972) that was flanked by 9 bp target site
duplications, consistent with transposition via ISAba1
and a novel insertion sequence deposited under ISfinder
as ISAba33 (Fig. 3). As the oxa23 transposons were mobi-
lized by insertion sequences, which appear in multiple
copies in the GC2 genomes, it was not possible to deter-
mine the precise insertion sites of the oxa23 transposons
in each genome. For most oxa23 isolates, the gene was
present in one, two or three copies (Fig. S1) and the
assembly data indicated that all the ISAba1 insertions
were chromosomal (Table 1). In contrast, the two GC1
isolates had low copy number for oxa23 (0.4–0.5) and
harboured an Aci6-type plasmid carrying AbaR4 within
which a copy of ISAba1 was present. This is consistent
with plasmid carriage of the oxa23 genes in these isolates,
similar to an earlier report of GC1 isolates carrying
Tn2006 within AbaR4 in an Aci6 plasmid (Hamidian
et al., 2014).
Emergence of imipenem resistance in
A. baumannii GC2
The genomic data showed that the majority of imipenem-
resistant VAP isolates belonged to GC2 (82.5 %) and all
0
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Fig. 2. Temporal changes in the MICs of imipenem. Each point represents a single isolate, coloured to indicate clonal group. Black points
indicate the mean MIC for each year, joined by red lines to show trend.
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such strains carried the oxa23 gene, consistent with our
previous work linking imipenem resistance to an oxa23-
positive clonal group with VNTR pattern MLVA6 (Nhu
et al., 2014). This pattern could result equally from the
introduction of a new resistant GC2 subclone or from
de novo emergence of resistance within the previously
circulating GC2 population. We aimed to use the whole-
genome data to distinguish between these possibilities
and also sought to investigate whether the acquisition of
oxa23 occurred only once or on multiple occasions.
The genome-wide ML tree for the GC2 isolates showed
that the imipenem-resistant VAP isolates fell into multiple
groups, many of which were genetically distant from the
earlier asymptomatic carriage isolates (File S1). However,
it was clear from the distribution of SNPs in the alignment
that there was substantial recombination affecting the
GC2 genomes (Fig. S4a, File S1). As recombination can
confound phylogenetic inference and intra-clonal relation-
ships, we sought to recover a better estimate of vertical
evolutionary signal within the GC2 isolates by first identi-
fying and then removing recombinant SNPs prior to
phylogenetic inference. Recombinant SNP detection
was performed using both ClonalFrameML (Didelot &
Wilson, 2015) and Gubbins (Croucher et al., 2015).
The Gubbins analysis yielded an apparently reliable recom-
bination-filtered alignment of 457 SNPs, which displayed
no spatial clustering of SNPs, a tree-like split network
structure and strong clock-like (linear) temporal signal
(r 250.73, Fig. S4c; compare with the ClonalFrameML-
filtered alignment in Fig. S4b or the raw data in Fig. S4a).
Based on these estimates of 457 non-recombinant SNPs pos-
itions and comparing with the 13 493 recombinant SNPs,
we estimate the ratio of SNPs introduced into the local
GC2 population by recombination to those introduced by
substitution mutation (r/m) to be *30. On the Gubbins
recombination-filtered alignment, we performed a time-
calibrated Bayesian analysis using BEAST, which yielded a
substitution rate of 9.7 SNPs per year [95 % highest pos-
terior density (HPD) 8–11, ESS ww1000].
In the resulting recombination-free GC2 BEAST tree
(Fig. 4), the carbapenem-susceptible carriage isolates
were divided into two well-supported lineages, which
Table 1. The genetic environment of acquired carbapenemase genes
Isolate or group No.
isolates
Imipenem MIC
(mg ml21)
Gene Mobile
element
Depth
ratio*
Chromosomal insertions of
carbapenemases
Plasmid
location1
CopiesD Predicted
site(s)d
GC2 (A) 1 64 oxa23 Tn2006 0.7 1 ABK1_1281 or ABK1_2910 –
GC2 (B) 2 32 oxa23 Tn2008VAR 0.7–0.9 1 ABK1_0148 –
2 64 oxa23 Tn2008VAR 1.5–1.7 2 ABK1_0148+ABK1_3166 –
GC2 (C) 9 64 oxa23 Tn2006 1.5–1.8 2 ABK1_3492 –
7 64 oxa23 Tn2006 2.4–2.7 3 ABK1_3492
GC2 (D) 7 64 oxa23 Tn2006 0.8–0.9 1 ABK1_0857 or ABK1_2018
or ABK1_2567
–
GC2 (E) 19 64 oxa23 Tn2006 0.6–0.9 1 ABK1_2948 or ABK1_2960 –
CC10 (KL8) 3 64 oxa23 Tn2006 0.9–1.1 1 ABK1_3165 –
1 64 oxa23 Tn2006 1.9 2 ABK1_3165 –
BAL_329 (CC10) 1 64 oxa23 Tn2006 0.7 1 ABK1_125 or ABK1_2164
or ABK1_2755
–
GC1 2 64 oxa23 Tn2006 0.4–0.5 – – a
BAL_212 (ST52) 1 64 oxa23 Tn2006 1.09 – – a
BAL_103 1 0.5 oxa23 Tn2006 0.07 – – b
UV 1268 (CC10) 1 1.5 oxa58 ISAba3 0.38 – – c
BAL_283, BAL_287 (CC16) 2 0.75–1.5 oxa58 ISAba3 0.5–0.8 – – c
BAL_255, 255_n (CC16) 2 64 oxa58 ISAba3 0.5–0.6 – – c
ndm1 Tn125 0.4–0.7 1 ABK1_1257 –
BAL_205, BAL_322 2 64 oxa58 ISAba3 0.5–0.8 – – d
ndm1 Tn125 0.4–0.7 – d
BAL_204 1 24 oxa40 – 2.7 – – e
* Ratio of mean read depths for the carbapenemase gene versus known chromosomal genes (see Fig. S2).
DCarbapenemase gene copy number estimated from the depth ratio (see distributions in Fig. S1).
dPossible insertion site(s) for the carbapenemase-carrying mobile element (details of ISAba1 sites are shown in Fig. S5).
1Key: a, Aci6 type plasmid, ISAba1 site in AbaR4; b, possibly lost during culture cross-contamination (note low read depth); c, novel plasmid
p255n_1 (deposited under GenBank accession number KT852971); d, possible novel plasmids; e, novel plasmid pBAL_204 (deposited under
GenBank accession number KT946773).
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diverged around 2002 (95 % HPD 2001–2003, effective
sample size ww1000). All of the imipenem-resistant
GC2 VAP isolates belonged to lineage 2; however, these
were paraphyletic and formed five distinct, strongly sup-
ported subclades (labelled A–E, Fig. 4). The most recent
common ancestor (MRCA) of all imipenem-resistant
GC2 VAP isolates was the same as the MRCA of the imi-
penem-susceptible lineage 2 carriage isolates, indicating
that the resistant clades emerged from within the pre-
viously circulating susceptible population of lineage 2.
The ML phylogeny showed a similar topology with
100 % bootstrap support for these subclades (Fig. S4c).
All imipenem-resistant GC2 isolates carried oxa23 and each
subclade had a unique clade-specific ISAba1 insertion site in
the chromosome (Table 1, Fig. S5), consistent with unique
insertions of Tn2006 or the Tn2008VAR transposon in each
subclade. The 95 % HPDs for the MRCA date of each sub-
clade are consistent with these acquisition events occurring
around or after the approval of imipenem for empirical treat-
ment of VAP on this ICU, in 2008 (Fig. 4). Copy number of
the oxa23 gene was apparently associated with MIC: within
subclade 2B (i.e. in the isolates containing the oxa23 amino
acid sequence variant in Tn2008VAR), isolates with one
copy of oxa23 displayed an MIC of 32 mg ml21 and isolates
with two copies displayed an MIC of 64 mg ml21; outside of
subclade 2B, isolates with at least a single copy of Tn2006 dis-
played an MIC of 64 mg ml21. These data indicate that
imipenem resistance arose in situ within the local GC2 popu-
lation on at least five separate occasions, coinciding with the
introduction of imipenem for empirical use on the ICU.
Capsule replacement in GC2 A. baumannii
The regions we identified as being affected by recombina-
tion in the local GC2 population included the KL, which
encodes capsule biosynthesis. Vaccines that target capsule
polysaccharides are an alternative to antibiotics in the con-
trol of pan-resistant Gram-negative bacterial infections.
Notably, we detected four distinct KLs amongst the GC2
isolates, consistent with capsule replacement induced via
homologous recombination. Amongst the 66 GC2 isolates,
24 carried the KL2 gene cluster (Kenyon & Hall, 2013), 18
carried KL49 (Kenyon et al., 2015), 23 carried a novel
gene cluster that we designated KL58 (Figs 5a and 6) and
one carried KL32 (same sequence as PSgc21 in Hu et al.,
2013). Variation in KLs was mirrored by allelic variation
in the gpi locus, which is utilized in the University of
Oxford MLST scheme (Table S1) and is located within the
KL. The genetic structures of these four KLs (Fig. 6) revealed
distinct saccharide processing genes in each locus; hence,
they are expected to produce distinct surface polysacchar-
ides, although to date the precise structures have been deter-
mined only for K2 and K49 (Kenyon et al., 2014;
Senchenkova et al., 2014; Vinogradov et al., 2014).
Nearly all of the early GC2 isolates carried KL2, which was
not represented in the non-GC2 isolates. Treating KL type
as a discrete trait, ancestral state reconstruction on the GC2
BEAST tree set identified KL2 as the most likely type in the
MRCA of all GC2 genomes in this collection (Fig. S6).
A maximum of four pairwise SNPs were detected amongst
the KL2 sequences and the SNPs flanking the KL2 locus
ISAba1
novel IS (ISAba33)
(89% similarity with ISAba1)
ISAba1
500 nt
Tn2008
9bp TSD 9bp TSD
9bp TSD 
(GTTTAAAAT)
9bp TSD
(GTTTAAAAT)
Tn2008VAR
(AAGCGACTC) (AAGCGACTC)
orf1 orf2 orf1 orf2
orf1 orf2
oxa23*
oxa23
(AAA ATPase)
a
b
Fig. 3. Genetic structure of the Tn2008-like transposon. Arrows indicate protein-coding genes, showing the direction of transcription and
labelled with their assigned gene names. Genes are coloured to indicate function: blue, transposase; pink, carbapenemase; brown, other.
Insertion sequences, which include transposase ORFs and flanking sequences, are shaded yellow. Flags indicate the presence of target
site duplications (TSDs) that are formed upon transposition, which are labelled with the duplicated sequence. (a) Tn2008-like transposon
of A. baumannii strain BAL_056 (Tn2008VAR, GenBank accession number KT852972, novel insertion sequence submitted to ISfinder as
ISAba33, the asterisk indicates a SNP leading to amino acid substitution L125V). (b) Tn2008 transposon of A. baumannii strain
08325850 (GenBank accession number KP780408).
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did not vary markedly between our GC2 KL2 isolates,
consistent with shared inheritance of the KL2 region
from a common ancestor carrying this locus and flanking
sequence. A de novo assembly and alignment of all KL2
sequences identified an insertion of the ISAba1 transposase
next to wzc, the first gene of KL2, in the GC2 lineage 1 iso-
lates; however, this is unlikely to affect expression of KL
genes as it is located downstream of the wzc ORF (Fig. 5a).
The majority of the remaining non-KL2 GC2 isolates
harboured either the KL49 or KL58 capsule genes
(Fig. 5b). Notably, both KL49 and KL58 were also ident-
ified in CC10 carriage isolates and VAP isolates from
2003 to 2006, providing a potential source for these
sequences within the local A. baumannii population.
Detailed inspection of the KL and surrounding sequences
in GC2 and CC10 isolates indicated that the KL49 GC2
strains most likely resulted from a single importation of
750 kb (spanning the KL49 locus) into the ancestor of
GC2 clade 2E, derived from co-circulating CC10 KL49
strains (or from a third donor that also donated KL49
and flanking sequence to the co-circulating GC2 and
CC10 clones) (Fig. 5b). Two variants of KL58 were ident-
ified: one in GC2 and the other in CC10. The GC2 KL58
sequence appears to be a hybrid of KL2 and the CC10
KL58 sequence (Fig. 5a), resulting from a local homo-
logous recombination event, in which 24 kbp towards the
39 of the KL58 locus was imported from CC10 (or from
a third donor that also donated KL58 and flanking
sequence to the co-circulating GC2 and CC10 clones).
The GC2 KL58 isolates formed a single monophyletic
group (subclades 2A–C, MRCA around 2005; Fig. 5b) con-
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Fig. 4. Recombination-filtered core genome phylogeny for GC2 A. baumannii in the ICU. BEAST maximum clade credibility tree; shading
indicates the period during which imipenem was used for the empirical treatment of VAP in the ICU. Isolate labels are coloured to indicate
source: red, VAP; blue, asymptomatic carriage. Node bars indicate 95 % HPDs for divergence dates; node labels and branch line thick-
ness indicate posterior support. The two main lineages (1 and 2) and five imipenem-resistant subclades (A–E) referred to in the text are
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sistent with a single import resulting in the formation of
the recombinant KL58 locus. However, within this group
was a single isolate (BAL_058) that carried a distinct KL,
KL32, which was not identified in any other isolate
(Fig. 5b). SNP variation on either side of the KL32 locus
was indicative of a recombination import spanning
*120 kb. In addition, a single isolate (BAL_339) nested
within the KL49 subclade 2E carried a KL58 sequence iden-
GC2 KL2
GC2 hybrid KL58
CC10 KL58
0 kb 5 kb 10 kb 15 kb 20 kb 25 kb
0 kb 5 kb 10 kb 15 kb 20 kb 25 kb
0 kb 5 kb 10 kb 15 kb 20 kb 25 kb
b
a ISAba1
Day of isolation
2000 2001 2002 2003 2004 2005 2006 2008 20092007 2010 2011 2012
Lineage 1
Lineage 2
A
B
C
D
E
Import KL49 from 
CC10 (~750 kb)
KL2 
ancestral
ISAba1 
insertion Import KL32 
(~120 kb),
unknown source
Import right end 
of KL58 from 
CC10 (~24  kb)
KL extent
wzc pgm Ildp
fkpA
Fig. 5. Capsule variation in the GC2 A. baumannii. (a) Schematic representation of a recombination event affecting the KL in GC2; the
extent of the capsule biosynthesis gene cluster is indicated by the black bar. Arrows indicate protein-coding genes showing the direction
of transcription, with selected genes labelled; KL2 genes are coloured black, typical KL58 genes are coloured blue; GC2 KL58 is a hybrid
of KL2 genes (black) and KL58 genes (blue). Grey shaded blocks indicate sequence homology, black overlaid lines indicate SNPs.
(b) Dated GC2 phylogeny showing KL recombination dynamics. Branches are coloured by capsule type and labelled by horizontal transfer
events affecting the KL; subclades A–E are labelled with red and yellow arrows indicating oxa23 transposon events (as in Fig. 4).
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tical to the hybrid KL58 sequence found in GC2 2A–C iso-
lates, suggesting it was acquired from a GC2 strain.
Capsule replacement is not well studied amongst Gram-
negative bacteria, but has recently been observed in multi-
ply antibiotic-resistant epidemic clones of A. baumannii
(Kenyon & Hall, 2013; Kenyon et al., 2014, 2015),
K. pneumoniae CC258 (Wyres et al., 2015) and E. coli
ST131 (Alqasim et al., 2014). Potential drivers of capsule
diversification include host immunity, phage predation
and also antimicrobial resistance as it has recently been
shown that capsule variation in A. baumannii is associated
with variation in susceptibility to multiple antimicrobials
(Geisinger & Isberg, 2015). Here, two of the KL replace-
ment events resulted in novel clades, i.e. KL58 GC2 (2A–C)
and KL49 GC2 (2E), that were successful in persisting
within the local population for several years. The local
maintenance of KL2 GC2 alongside these newer variants
indicates that if there was selection for capsule variation
in the local population, this was not strong enough to
drive clonal replacement of KL2 GC2 in this instance.
Conclusions
Our analyses indicate that the recent surge of imipenem-
resistant VAP in this ICU was attributable to multiple imi-
penem-resistant clones, the majority of which arose from
within the local A. baumannii population via the acqui-
sition of mobile carbapenemase genes. Whilst precise
details of imipenem usage are not available, these acqui-
sition events occurred at around the same time at which
imipenem was approved for empirical treatment of VAP
on the ward, consistent with the hypothesis that the
change in treatment strategy drove rapid changes in
the local population of A. baumannii and resulted in the
repeated emergence of multiple imipenem-resistant sub-
clones from within the local population. This scenario con-
trasts with recent genomic investigations of epidemics of
carbapenem-resistant Gram-negative clones in other hospital
settings, which have reported transmission of a singular resist-
ant clone (Mathers et al., 2015; Snitkin et al., 2012), compe-
tition between resident and incoming resistant clones
(Bran˜as et al., 2015) or transmission of a resistant plasmid
amongst diverse bacterial hosts (Mathers et al., 2011, 2015).
Diversification of capsule types within GC2 appears to
have commenced at around the same time as the emer-
gence of imipenem resistance in the population and was
driven by homologous recombination. The fact that we
were able to identify likely donors for two of the imported
capsule loci amongst previously circulating strains of the
second most common A. baumannii clone on the ward
(CC10) is notable. It suggests that whilst the population
of A. baumannii on the ward is diverse, consisting of
multiple strains, this population may nevertheless have
remained ‘closed’, with evidence of reassortment between
strains, but limited evidence for the introduction of new
genetic material – a finding consistent with that observed
in Enterococcus faecium by van Hal et al. (2016). Interest-
ingly, the earliest examples of the oxa23 carbapenemase
on the ward were two GC1 carriage isolates from 2007,
which are the only examples of GC1 we identified in this
setting and provide a potential external source for the
introduction of the oxa23 carbapenemase into the local
A. baumannii population.
Similar to the findings of Wright et al. (2014), our investi-
gations underscore the importance of whole-genome
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Fig. 6. Genetic structure of KLs identified in the GC2 A. baumannii isolates. Gene clusters are drawn to scale against KL2 reference
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sequence analysis to tease apart fine-scale evolutionary
events within bacterial pathogen populations, as our earlier
MLVA and PCR analyses could not distinguish the pre-
sence of distinct subclades of GC2 that had independently
evolved imipenem resistance.
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